Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

Clinical Pharmacology and Therapeutics
Delia A DempseyNeal L Benowitz

Abstract

Nicotine and a variety of other drugs and toxins are metabolized by cytochrome P450 (CYP) 2A6. Our objective was to evaluate the use of oral nicotine with measurement of the trans-3'-hydroxycotinine (3HC)/cotinine (COT) metabolite ratio as a noninvasive probe of CYP2A6 activity. Sixty-two healthy volunteers received an oral solution of deuterium-labeled nicotine (2 mg) and its metabolite cotinine (10 mg). Plasma nicotine and plasma and saliva cotinine and 3HC concentrations were measured over time. The 3HC/COT ratio derived from deuterium-labeled cotinine, measured in either plasma (2-8 hours after administration) or saliva (at 6 hours), was strongly correlated with the oral clearance of nicotine (r = 0.76-0.83, depending on the time of measurement). The 6-hour 3HC/COT ratio from nicotine derived from tobacco in 14 smokers was highly correlated with the ratio derived from deuterium-labeled nicotine (r = 0.88) and was also highly correlated with the oral clearance of nicotine (r = 0.90). Two subjects homozygous for inactive CYP2A6 alleles produced no 3HC, confirming the specificity of the metabolite ratio. The 3HC/COT ratio was also highly correlated with the clearance and half-life of cotinine, consistent with the fact that cot...Continue Reading

Citations

Jan 25, 2012·European Journal of Clinical Pharmacology·Utkarsh KohliDaniel Kurnik
Feb 1, 2012·Human Genetics·Allison B Gold, Caryn Lerman
Feb 28, 2013·Journal of Exposure Science & Environmental Epidemiology·Sharon E MurphyAnne Joseph
Feb 16, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mehmet SofuogluPeter Jatlow
Mar 14, 2013·Journal of Addictive Diseases·Robert A SchnollBrian Hitsman
Jun 28, 2008·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Megan E PiperTimothy B Baker
May 5, 2010·DNA and Cell Biology·Reza Entezari HeraviJavad Behravan
Jul 10, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Mark D EisnerPaul D Blanc
Jun 16, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Neal L BenowitzPeyton Jacob
Aug 25, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Hans J RoethigPaul E Mendes
Oct 31, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Melbourne F HovellNeal L Benowitz
Jun 30, 2010·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jill M WilliamsNeal L Benowitz
Mar 10, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Mary FalconeRiju Ray
May 7, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Neal L BenowitzPeyton Jacob
Feb 10, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jill M WilliamsNeal L Benowitz
May 17, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Robert A SchnollNeal L Benowitz
Mar 21, 2009·Pharmacogenetics and Genomics·Gary E SwanNeal L Benowitz
Nov 10, 2009·Pharmacogenetics and Genomics·Caroline F ThornRuss B Altman
May 21, 2011·Pharmacogenetics and Genomics·Joseph BloomSharon E Murphy
Jan 10, 2012·Pharmacogenetics and Genomics·Gang ChenPhilip Lazarus
May 10, 2012·Pharmacogenetics and Genomics·Matthew J BinningtonRachel F Tyndale
Apr 13, 2012·Pharmacogenetics and Genomics·Wonho LeeDavid V Conti
Aug 24, 2011·Therapeutic Drug Monitoring·Karl B ScheidweilerMarilyn A Huestis
Mar 23, 2012·The Journal of Pharmacology and Experimental Therapeutics·Colin S CunninghamLance R McMahon
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Jibran Y KhokharRachel F Tyndale
Jan 11, 2007·Annual Review of Pharmacology and Toxicology·Eric C K Siu, Rachel F Tyndale
Oct 7, 2008·Annual Review of Pharmacology and Toxicology·Neal L Benowitz
Jun 19, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Marc E MooneyDorothy K Hatsukami
Nov 26, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kiersten S DerbyLoïc Le Marchand
Dec 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Man Ki HoRachel F Tyndale
May 8, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Neal L BenowitzPeyton Jacob
Aug 20, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jill M WilliamsNeal L Benowitz
Jan 8, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Andrew A StrasserCaryn E Lerman
Oct 22, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Neal L BenowitzPeyton Jacob
May 4, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gideon St HelenNeal L Benowitz
Apr 7, 2007·American Journal of Respiratory and Critical Care Medicine·Sigal Ben-Zaken CohenDon D Sin
Apr 8, 2011·American Journal of Respiratory and Critical Care Medicine·Carolyn S CalfeeMitchell J Cohen
Jun 8, 2006·BMC Pulmonary Medicine·Mark D EisnerPaul D Blanc
Sep 3, 2008·Pediatrics·Mark L RubinsteinAnna-Barbara Moscicki

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Marc E MooneyDorothy Hatsukami
Clinical Pharmacology and Therapeutics
Neal L BenowitzRachel F Tyndale
© 2022 Meta ULC. All rights reserved